Human Genetics

, Volume 95, Issue 6, pp 651–656

Genome-wide loss of maternal alleles in a nephrogenic rest and Wilms' tumour from a BWS patient

  • Paul R. Hoban
  • Jim Heighway
  • Gavin R. M. White
  • Bart Baker
  • Jackie Gardner
  • Jill M. Birch
  • Pat Morris-Jones
  • Anna M. Kelsey
Original Investigation


A patient with Beckwith-Wiedemann syndrome (BWS) presented with Wilms' tumour. Examination of the nephrectomy specimen showed, in addition to the tumour, the presence of nephrogenic rests. Nephrogenic rests are thought to be precursor lesions from which a Wilms' tumour may develop. A molecular analysis examining the loss of constitutional heterozygosity (LOCH), initially for chromosome 11, was performed on peripheral blood, the normal kidney, nephrogenic rest and tumour material. The study was extended to include markers from all 23 chromosomes. At each informative, locus, LOCH of the maternal allele was shown in the nephrogenic rest and tumour material. In addition, the normal kidney displayed allele imbalance. It would appear from these results that either extensive LOCH across the genome was an early genetic event in the development of malignancy in this patient or that the tumour and rest developed from cells containing no maternal chromosomes. The apparent LOCH seen in the normal kidney sample implies that full reduction to homozygosity is consistent with a histologically normal appearance. Putative mechanisms to explain this phenomenon are discussed.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Armstrong JF, Pritchard-Jones K, Bickmore W, Hastie ND, Bard JBL (1992) The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev 40:85–97Google Scholar
  2. Baker BW, Heighway J, Broweth PJ, Norton JD (1993) A polymerase chain reaction-based method for the detection of trisomy 12 in B chronic lymphocytic leukaemia. Br J Haematol 85:179–181Google Scholar
  3. Beckwith JB (1993) Precursor lesions of Wilms' tumour: clinical and biological implications. Med Pediatr Oncol 21:158–168PubMedGoogle Scholar
  4. Beckwith JB, Kviat NB, Bonadio JF (1990) Nephrogenic rests, nephroblastomatosis and the pathogenesis of Wilms' tumour. Pediatr Pathol 10:1–36PubMedGoogle Scholar
  5. Call KM, Glaser TM, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yager H, Lewis HH, Jones CA, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumour locus. Cell 60:509–520CrossRefPubMedGoogle Scholar
  6. Chao L-Y, Huff V, Tomlinson G, Riccardi VM, Strong LC, Saunders GF (1993) Genetic mosaicism in normal tumour tissues of Wilms' patients. Nature Genet 3:127–131Google Scholar
  7. Dressler LG, Bartow SA (1989) DNA flow cytometry in solid tumours; practical aspects and clinical applications. Semin Diagn Pathol 6:55–82Google Scholar
  8. Gartler SM, Riggs AD (1983) Mammalian X-chromosome inactivation. Annu Rev Genet 17:155–190CrossRefPubMedGoogle Scholar
  9. Giannoukakis N, Deal C, Paquette J, Goodyer CG, Polychronakos C (1993) Parental genomic imprinting of the human IGF2 gene. Nature Genet 4:98–101Google Scholar
  10. Glaser T, Housman D, Lewis WH, Gerhard D, Jones CA (1989) A fine structure deletion map of human chromosome 11p: analysis of J1 series hybrids. Somat Cell Mol Genet 15:477–501Google Scholar
  11. Grundy P, Koufos A, Morgan K, Li FP, Meadows AJ, Cavenee W (1988) Familial predisposition to Wilms tumour does not map to the short arm of chromosome 11. Nature 336:374–376Google Scholar
  12. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housmann DE (1990) An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumour. Cell 67:1257–1269Google Scholar
  13. Heighway J (1991) HaeIII polymorphism within 3′ untranslated region of PRAD1. Nucleic Acids Res 19:5452Google Scholar
  14. Henry I, Bonaiti-Pellie C, Chehensse V, Beldjord C, Schwartz C, Utermann G, Junien C (1991) Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 351:665–670Google Scholar
  15. Hoban PR, Santibanez-Koref MF, Kelsey AM (1991) Polymorphism in exon 1 of the c-Ha-ras gene (HRAS). Nucleic Acids Res 19:6976Google Scholar
  16. Hoban PR, Kelsey AM (1991a) HaeIII polymorphism within intron A of the insulin gene detectable by PCR. Nucleic Acids Res 19:5091Google Scholar
  17. Hoban PR, Kelsey AM (1991b) Pst 1 polymorphism within the 3′ untranslated region of the insulin gene detectable by the polymerase chain reaction. Nucleic Acids Res 19:4576Google Scholar
  18. Hoban PR, Kelsey AM (1991c) HinfI polymorphism within the 3′ untranslated region of the candidate Wilms tumour gene. Nucleic Acids Res 19:1169Google Scholar
  19. Huff V, Compton DA, Chao L-Y, Strong LC, Geiser CF, Saunders GF (1988) Lack of linkage of familial Wilms' tumour to chromosomal band 11p13. Nature 336:377–379Google Scholar
  20. Huff V, Reeve AE, Leppert M, Strong LC, Douglass EC, Geiser CF, Li FP, Meadows A, Callen DF, Lenoir G, Saunders GF (1992) Non-linkage of 16q markers to familial predisposition to Wilms' tumour. Cancer Res 52:6117–6120Google Scholar
  21. Huff V, Saunders GF (1993) Wilms' tumour genes. Biochim Biophys Acta 115:295–306Google Scholar
  22. Jenkins ME, Elsen J, Sequin F (1971) Congenital asymmetry and diploid-triploid mosaicism. Am J Dis Child 122:80–84Google Scholar
  23. Knoll J, Nicholls R, Magenis R, Graham J, Lalande M, Latt S (1991) Angleman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet 32:285–290Google Scholar
  24. Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC, Kalibalyi A, Cavenee WK (1989) Familial WiedemannBeckwith syndrome and a second Wilms' tumour locus both map to 11p15.5. Am J Hum Genet 44:711–719Google Scholar
  25. Little M, Prosser J, Condie A, Smith PJ, Heyningen van V, Hastie ND (1992) Zinc finger point mutations within the WT1 gene in Wilms tumour patients. Proc Natl Acad Sci USA 89:4791–4795Google Scholar
  26. Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: a laboratory manual. Cold Spring Habor Laboratory, Cold Spring Habor, NYGoogle Scholar
  27. Maw MA, Grundy PE, Mellow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE, Callen DF, Thompson AD, Richards RI, Reeve AE (1992) A third Wilms tumour locus on chromosome 16q. Cancer Res 52:3094–3098Google Scholar
  28. Migeon BR (1994) X-chromosome inactivation: molecular mechanisms and genetic consequences. Trends Genet 10:230–235Google Scholar
  29. Orphanos V, McGrown G, Boyle JM, Santibanez-Koref MF (1993) Thirteen dinucleotide repeat polymorphisms on chromosome 6. Hum Mol Genet 2:2196Google Scholar
  30. Pal N, Wadey RB, Buckle B, Yeomans E, Pritchard J, Cowell JK (1990) Preferential loss of maternal alleles in sporadic Wilms'. Oncogene 5:1665–1668Google Scholar
  31. Parks S, Bernard S, Bove KE, Sens DA, Hazen-Martin A, Garvin J, Haber DA (1993) Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nature Genet 5:363–367Google Scholar
  32. Pelletier J, Bruening W, Kashtan CD, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser I, Fine RN, Silverman BL, Haber DA, Housman DE (1991) Germline mutations in the Wilms' tumour suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437–447Google Scholar
  33. Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP (1989) Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet 44:720–723Google Scholar
  34. Pritchard-Jones K, Flemming S (1991) Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumour: implications for tumour histogenesis. Oncogene 6:2211–2220Google Scholar
  35. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, Heyningen V van, Hastie N (1990) The candidate Wilms tumour gene is involved in genitourinary development. Nature 346:194–197CrossRefPubMedGoogle Scholar
  36. Reeve AE, Sih SA, Raizis AM, Feinberg AP (1989) Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumour cells. Mol Cell Biol 9:1799–1803Google Scholar
  37. Reik W (1989) Genomic imprinting and genetic disorders in man. Trends Genet 5:331–336Google Scholar
  38. Scrable HJ, Cavenee W, Ghavimi F, Lovell M, Morgan K Sapienza (1989) A model for embryonal rhabdomyosarcoma tumourigenesis that involves genome imprinting. Proc Natl Acad Sci USA 86:7480–7484Google Scholar
  39. Tadokoro K, Fujii H, Inoue T, Yamanda M (1991) Polymerase chain reaction (PCR) for the detection of Apa1 polymorphism at the insulin-like growth factor II gene (IGF2). Nucleic Acids Res 19:6967Google Scholar
  40. Tomlinson GE, Compton DA, Strong IC, Saunders GF (1991) PCR detection of a Bg/II RFLP at 11p13. Nucleic Acids Res 19:1718Google Scholar
  41. Wang-Wuu S, Soukup S, Bove K, Gotwals B, Lampkin B (1990) Chromosome analysis of 31 Wilms' tumour. Cancer Res 50:2786–2793Google Scholar
  42. Zhang Y, Tycko B (1992) Monoallelic expression of the human H19 gene. Nature Genet 1:40–44Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • Paul R. Hoban
    • 1
    • 2
  • Jim Heighway
    • 1
  • Gavin R. M. White
    • 1
  • Bart Baker
    • 3
  • Jackie Gardner
    • 2
  • Jill M. Birch
    • 4
  • Pat Morris-Jones
    • 2
  • Anna M. Kelsey
    • 2
  1. 1.CRC Department of Cancer GeneticsPaterson Institute of Cancer Research, Christie (CRC) Research TrustManchesterUK
  2. 2.Department of PathologyGiving for Living Research Centre, Royal Manchester Childrens HospitalManchesterUK
  3. 3.CRC Department of Gene RegulationChristie (CRC) Research TrustManchesterUK
  4. 4.CRC Paediatric and Familial Cancer Research Group, Christie (CRC) Research TrustManchesterUK

Personalised recommendations